Joshua Silverman Ayro, Inc. (AYRO) insider trading activity

Joshua Silverman is Director of AYRO, Inc.. Currently has a direct ownership of 395,493 shares of AYRO, which is worth approximately $304,529. The most recent transaction as insider was on Aug 01, 2023, when has been sold 12,740 shares (Common Stock) at a price of $0.82 per share, resulting in proceeds of $10,446. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 395K

0% 3M change

0% 12M change

Total Value Held $304,529

Joshua Silverman Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Aug 01 2023	SELL Open market or private sale	$10,446 $0.82 p/Share	12,740 Reduced 3.12%	395,493 Common Stock
May 03 2023	SELL Open market or private sale	$5,844 $0.49 p/Share	11,927 Reduced 2.84%	408,233 Common Stock
Feb 01 2023	BUY Grant, award, or other acquisition	-	197,333 Added 31.96%	420,160 Common Stock
Jan 30 2023	SELL Open market or private sale	$5,091 $0.71 p/Share	7,171 Reduced 3.12%	222,827 Common Stock
Nov 01 2022	SELL Open market or private sale	$4,230 $0.59 p/Share	7,171 Reduced 3.02%	229,998 Common Stock
May 11 2022	SELL Open market or private sale	$10,541 $0.82 p/Share	12,855 Reduced 5.14%	237,169 Common Stock
Feb 01 2022	BUY Grant, award, or other acquisition	-	114,729 Added 31.45%	250,024 Common Stock
Jun 04 2021	SELL Open market or private sale	$201,671 $5.17 p/Share	39,008 Reduced 22.38%	135,295 Common Stock
Feb 24 2021	BUY Grant, award, or other acquisition	-	42,000 Added 19.42%	174,303 Common Stock
Sep 29 2020	BUY Grant, award, or other acquisition	-	122,547 Added 48.09%	132,303 Common Stock

Also insider at

PTPI

Petros Pharmaceuticals, Inc. Healthcare

Director

MYMD

MyMD Pharmaceuticals, Inc. Healthcare

Director

SNPX

Synaptogenix, Inc. Healthcare

Director

FEMY

FEMASYS INC Healthcare

PMCB

PharmaCyte Biotech, Inc. Healthcare

Interim CEO, Interim President